All In MedTech

FDA Clearance Tracker · P070014-S014

LIFESTENT VASCULAR STENT SYSTEMS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 18, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P070014-S014
Device name
LIFESTENT VASCULAR STENT SYSTEMS
Applicant location
Tempe, AZ
Received
Apr 13, 2010
Decided
Oct 18, 2010
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P070014

Device type

Device class
Class III

Every decision under product code NIP

FDA's approval statement

As written in FDA's record.

APPROVAL OF THE POST-APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Bard Peripheral Vascular, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.